CRISAFULLI, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 1.624
NA - Nord America 1.486
AS - Asia 1.051
OC - Oceania 48
SA - Sud America 16
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.240
Nazione #
US - Stati Uniti d'America 1.424
IT - Italia 680
CN - Cina 669
DE - Germania 173
GB - Regno Unito 145
FR - Francia 109
CZ - Repubblica Ceca 105
JP - Giappone 81
IN - India 73
ES - Italia 67
NL - Olanda 66
HK - Hong Kong 59
RU - Federazione Russa 57
CA - Canada 47
AU - Australia 39
CH - Svizzera 30
SE - Svezia 30
KR - Corea 28
VN - Vietnam 23
SG - Singapore 22
RO - Romania 19
UA - Ucraina 19
AT - Austria 16
DK - Danimarca 15
GR - Grecia 15
MY - Malesia 15
PL - Polonia 15
MX - Messico 14
TW - Taiwan 14
TR - Turchia 12
FI - Finlandia 11
HU - Ungheria 11
IL - Israele 11
BE - Belgio 10
IE - Irlanda 10
TH - Thailandia 10
NZ - Nuova Zelanda 9
IR - Iran 8
ZA - Sudafrica 8
BR - Brasile 6
CL - Cile 6
PT - Portogallo 6
NO - Norvegia 5
JO - Giordania 4
BD - Bangladesh 3
EG - Egitto 3
ID - Indonesia 3
MK - Macedonia 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
KZ - Kazakistan 2
PK - Pakistan 2
A1 - Anonimo 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PE - Perù 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 4.240
Città #
Fairfield 103
Shanghai 91
Beijing 90
Torino 86
Ashburn 79
Houston 79
Milan 76
Seattle 72
Santa Cruz 66
Woodbridge 65
Buffalo 61
Cambridge 50
Turin 45
Guangzhou 41
Wilmington 34
Ann Arbor 31
Nanjing 31
Rome 28
Wuhan 28
Barcelona 25
University Park 23
Xian 22
Boston 21
New Orleans 21
Shenyang 21
Los Angeles 20
London 19
Tianjin 19
Chicago 18
Hangzhou 18
Tokyo 18
Changsha 17
Chongqing 17
Riva 17
Carrara 16
Chengdu 16
New York 16
Singapore 16
Vienna 16
Zurich 16
Nürnberg 14
Dong Ket 13
Naples 13
Nanning 12
Lake Forest 11
Norwalk 11
Pisa 11
Redmond 11
Taipei 11
Central 10
Central District 10
Chennai 10
Hamilton 10
San Diego 10
Toronto 10
Warsaw 10
Berlin 9
Boardman 9
Council Bluffs 9
Dallas 9
Helsinki 9
Hyderabad 9
Las Vegas 9
Ottawa 9
Tappahannock 9
Bengaluru 8
Dearborn 8
Fuzhou 8
Genoa 8
Hefei 8
Munich 8
Paris 8
Rochester 8
San Jose 8
Stanford 8
Absecon 7
Arezzo 7
Changchun 7
Falls Church 7
Kuala Lumpur 7
Philadelphia 7
San Francisco 7
Seoul 7
Settimo Torinese 7
Zhengzhou 7
Bergamo 6
Birmingham 6
Bologna 6
Brescia 6
Clearwater 6
Flayosc 6
Harbin 6
Heidelberg 6
Leipzig 6
Luni 6
Menlo Park 6
Miami 6
Mountain View 6
Mumbai 6
Parsippany 6
Totale 2.046
Nome #
Adaptive mutability of colorectal cancers in response to targeted therapies, file e27ce42e-f361-2581-e053-d805fe0acbaa 871
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-7e04-2581-e053-d805fe0acbaa 749
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer, file e27ce427-2d1b-2581-e053-d805fe0acbaa 291
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor, file e27ce42b-ad33-2581-e053-d805fe0acbaa 236
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions, file e27ce42b-9069-2581-e053-d805fe0acbaa 221
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer, file e27ce42a-9432-2581-e053-d805fe0acbaa 214
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer, file e27ce42b-fd7d-2581-e053-d805fe0acbaa 204
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce428-ee7a-2581-e053-d805fe0acbaa 184
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file e27ce435-9a5d-2581-e053-d805fe0acbaa 171
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases, file e27ce42c-7e06-2581-e053-d805fe0acbaa 152
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology, file e27ce42e-7735-2581-e053-d805fe0acbaa 149
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients, file e27ce428-f6ea-2581-e053-d805fe0acbaa 145
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer, file e27ce435-6233-2581-e053-d805fe0acbaa 106
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer, file e27ce429-176a-2581-e053-d805fe0acbaa 95
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer, file e27ce429-1433-2581-e053-d805fe0acbaa 80
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy, file e27ce432-19bb-2581-e053-d805fe0acbaa 66
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor, file e27ce42b-c004-2581-e053-d805fe0acbaa 61
Tracking colorectal cancer evolution in time and space, file e27ce42c-1eea-2581-e053-d805fe0acbaa 59
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file e27ce435-9a5b-2581-e053-d805fe0acbaa 45
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study, file e27ce434-7d1c-2581-e053-d805fe0acbaa 43
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor, file e27ce42c-29ea-2581-e053-d805fe0acbaa 34
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells, file eddce5b7-5d9a-414e-811a-e6a359372a96 22
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells, file 0680489c-fa68-4090-80fb-bcf874f958a2 21
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer, file e27ce42d-8306-2581-e053-d805fe0acbaa 20
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial, file c692a1ce-a732-4420-b13d-5160454ff92d 15
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination, file 2ffec199-1478-4bf3-9443-bc395c5485aa 14
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient, file d82de37f-401b-46a4-8b57-899917d6fc66 9
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file f2908de7-b6e6-471c-be4a-be1fde87a37a 9
Adaptive mutability of colorectal cancers in response to targeted therapies, file e27ce42e-f362-2581-e053-d805fe0acbaa 8
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file e27ce435-9a5c-2581-e053-d805fe0acbaa 8
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-77f6-2581-e053-d805fe0acbaa 7
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce432-5e80-2581-e053-d805fe0acbaa 7
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology, file e27ce42e-7a1f-2581-e053-d805fe0acbaa 6
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas, file 591b77a4-c43c-4561-8bfb-58fc797a0dcf 4
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer, file e27ce428-9ee6-2581-e053-d805fe0acbaa 2
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy, file e78d2eaa-9fe7-4e13-a3d9-e26539b5fc4a 2
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer, file 94742628-0260-4533-9b49-348baf809267 1
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer, file e27ce429-13c3-2581-e053-d805fe0acbaa 1
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer, file e27ce429-142a-2581-e053-d805fe0acbaa 1
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce429-cb90-2581-e053-d805fe0acbaa 1
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor, file e27ce42b-e474-2581-e053-d805fe0acbaa 1
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer, file e27ce42c-3b7a-2581-e053-d805fe0acbaa 1
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce432-4e12-2581-e053-d805fe0acbaa 1
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer, file e27ce432-5d0a-2581-e053-d805fe0acbaa 1
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology, file e27ce432-5ec5-2581-e053-d805fe0acbaa 1
Totale 4.339
Categoria #
all - tutte 6.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019194 0 0 0 0 0 0 0 0 0 46 88 60
2019/2020823 62 39 26 68 45 58 59 95 99 86 102 84
2020/2021912 64 95 70 119 83 89 50 69 62 106 73 32
2021/2022964 63 77 77 85 95 81 64 46 81 46 100 149
2022/2023979 83 59 143 113 89 82 82 81 120 65 49 13
2023/2024106 6 11 7 2 9 7 28 20 8 8 0 0
Totale 4.339